← Back to Search

Health Insurance Literacy Intervention for Cancer Survivors (CHAT-S Trial)

N/A

Waitlist Available

Research Sponsored by University of Utah

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 18 months

Awards & highlights

CHAT-S Trial Summary

This trial will test a virtual health insurance intervention to help young adult cancer survivors ages 26-39 gain knowledge, reduce financial burden, and improve surveillance for recurrence. Cost-effectiveness and budget impact analyses will be used to measure sustainability.

Who is the study for?

This trial is for young adult cancer survivors aged 26 to 45, who have been treated for breast, testicular, lymphoma, sarcoma, or colorectal cancer within the last year. Participants must speak English and be patients at specific Utah healthcare institutions.Check my eligibility

What is being tested?

The study tests a virtual health insurance navigation program called CHAT-S against usual care. It aims to improve insurance knowledge, reduce financial stress and enhance monitoring for cancer recurrence in participants through four sessions.See study design

What are the potential side effects?

Since this intervention involves education and counseling rather than medical treatment, traditional physical side effects are not expected. However, participants may experience emotional or cognitive discomfort while discussing sensitive topics like finances and health.

CHAT-S Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 18 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~18 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 18 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

COmprehensive Score for financial Toxicity (COST)

Health Insurance Literacy Measure

Health Insurance Literacy Measure (HILM)

Secondary outcome measures

Acceptability

COVID-19 Health Care Impacts

Cost related literacy

+6 more

CHAT-S Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: CHAT-SExperimental Treatment1 Intervention

CHAT-S consists of 4 bi-weekly 35-45 minute videoconferencing sessions with a patient navigator and a patient booklet on insurance, costs, and survivorship care.

Group II: Usual CarePlacebo Group1 Intervention

Usual care will consist of a resource list sent by the navigator.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of UtahLead Sponsor

1,095 Previous Clinical Trials

1,775,285 Total Patients Enrolled

Intermountain HealthUNKNOWN

Massachusetts General HospitalOTHER

2,928 Previous Clinical Trials

13,198,055 Total Patients Enrolled

Media Library

CHAT-S Clinical Trial Eligibility Overview. Trial Name: NCT05829070 — N/A

Cancer Research Study Groups: CHAT-S, Usual Care

Cancer Clinical Trial 2023: CHAT-S Highlights & Side Effects. Trial Name: NCT05829070 — N/A

CHAT-S 2023 Treatment Timeline for Medical Study. Trial Name: NCT05829070 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment accessible to those over 55 years of age in this research study?

"This research study is seeking participants between the ages of 26 and 45."

Answered by AI

What criteria must I meet in order to qualify for participation in this clinical trial?

"Individuals between 26 and 45 years old who have a cancer diagnosis are eligible to participate in this study. This trial currently seeks approximately 300 participants for enrollment."

Answered by AI

Are there any open spots in this clinical research?

"According to the clinicaltrials.gov database, this experiment is not accepting volunteers at present time. The trial was first posted on July 1st 2023 and last revised on April 12th of the same year. Nonetheless, there are many other trials that require participants in lieu of this one; 526 studies are actively searching for subjects as we speak."

Answered by AI

What results are investigators hoping to observe from this trial?

"The primary measure of success in this trial will be the COST score, collected at Baseline. Secondary outcomes include Survivorship Care Receipt (gathering information on visits to both PCPs and Oncologists), Insurance Coverage (public/private policyholder details) and consequences of the pandemic on medical care access and finances (working status changes)."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Improving Health Insurance Literacy Among Young Adult Cancer Survivors

Anne Kirchhoff 2023. "Improving Health Insurance Literacy Among Young Adult Cancer Survivors". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05829070.